A detailed history of Quinn Opportunity Partners LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 713,383 shares of BNTX stock, worth $57.3 Million. This represents 7.53% of its overall portfolio holdings.

Number of Shares
713,383
Previous 45,000 1485.3%
Holding current value
$57.3 Million
Previous $4.75 Million 1285.74%
% of portfolio
7.53%
Previous 0.51%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$88.96 - $112.35 $3.45 Million - $4.36 Million
38,800 Added 5.75%
713,383 $65.8 Million
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $1.38 Million - $1.71 Million
15,200 Added 2.31%
674,583 $71.2 Million
Q3 2023

Nov 14, 2023

BUY
$98.5 - $125.08 $24.6 Million - $31.2 Million
249,768 Added 60.98%
659,383 $71.6 Million
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $6.32 Million - $7.99 Million
61,650 Added 17.72%
409,615 $44.2 Million
Q1 2023

May 12, 2023

BUY
$122.57 - $153.67 $10.5 Million - $13.2 Million
85,894 Added 32.78%
347,965 $43.3 Million
Q4 2022

Feb 14, 2023

BUY
$118.43 - $186.05 $31 Million - $48.8 Million
262,071 New
262,071 $39.4 Million
Q3 2022

Nov 14, 2022

SELL
$127.65 - $183.11 $3.91 Million - $5.61 Million
-30,664 Reduced 10.2%
270,057 $36.4 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $12.5 Million - $18.9 Million
-101,518 Reduced 25.24%
300,721 $44.8 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $43.6 Million - $80 Million
345,049 Added 603.34%
402,239 $68.6 Million
Q4 2021

Feb 14, 2022

BUY
$216.64 - $362.52 $12 Million - $20 Million
55,190 Added 2759.5%
57,190 $14.7 Million
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $5.15 Million - $11.2 Million
-25,000 Reduced 92.59%
2,000 $546,000
Q2 2021

Aug 16, 2021

SELL
$113.32 - $241.49 $5.83 Million - $12.4 Million
-51,460 Reduced 65.59%
27,000 $6.05 Million
Q1 2021

May 13, 2021

BUY
$85.73 - $119.5 $5.91 Million - $8.24 Million
68,960 Added 725.89%
78,460 $8.57 Million
Q4 2020

Feb 11, 2021

BUY
$72.71 - $129.54 $690,744 - $1.23 Million
9,500 New
9,500 $774,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $19.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Quinn Opportunity Partners LLC Portfolio

Follow Quinn Opportunity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quinn Opportunity Partners LLC with notifications on news.